Lawrence Corey Selected Research

Infection

09/2007	Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection.
06/2007	Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein-Barr virus infection than younger renal transplant recipients.
10/2006	Selection on the human immunodeficiency virus type 1 proteome following primary infection.
04/2006	CD4+ T cell receptor repertoire perturbations in HIV-1 infection: association with plasma viremia and disease progression.
03/2006	Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients.
03/2006	High serum hepatitis C virus (HCV) RNA load predicts the presence of HCV RNA in saliva from individuals with chronic and acute HCV infection.
07/2005	Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: a two-year study.
12/2004	BK virus infection in hematopoietic stem cell transplant recipients: frequency, risk factors, and association with postengraftment hemorrhagic cystitis.
11/2004	Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy.
09/2004	Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation.
02/2004	Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants.
01/2004	Prolonged outbreak of human parainfluenza virus 3 infection in a stem cell transplant outpatient department: insights from molecular epidemiologic analysis.
06/2003	Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.
05/2003	Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia.
10/2002	Assessment of a combined testing strategy for detection of antibodies to human herpesvirus 8 (HHV-8) in persons with Kaposi's sarcoma, persons with asymptomatic HHV-8 infection, and persons at low risk for HHV-8 infection.
04/2002	Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.
04/2002	Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
02/2002	High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection.

Articles by Research Topic

Disease

18	Infection 09/2007 - 02/2002
4	Herpes Genitalis (Genital Herpes) 09/2006 - 04/2002
3	Aspergillosis 10/2005 - 12/2002
2	Viremia 04/2006 - 07/2003
2	Cystitis 08/2005 - 12/2004
2	Kaposi Sarcoma (Kaposi's Sarcoma) 06/2004 - 10/2002
2	Cytomegalovirus Infections (Inclusion Disease) 11/2003 - 03/2002
1	Herpes Simplex 01/2008
1	Paramyxoviridae Infections (Parainfluenza) 09/2007
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 06/2007
1	HIV Infections (HIV Infection) 06/2006
1	Hypersensitivity (Allergy) 06/2006
1	Disease Progression 04/2006
1	Chronic Hepatitis B 07/2005
1	Human Influenza (Influenza) 11/2004
1	Tissue Adhesions 09/2004
1	Giant Lymph Node Hyperplasia (Castleman's Disease) 03/2004
1	Adenoviridae Infections (Adenovirus Infections) 05/2003
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2002
1	Respiratory Tract Infections (Respiratory Tract Infection) 03/2002

Drug/Important Bio-Agent (IBA)

2	valacyclovir (valaciclovir)FDA LinkGeneric 09/2006 - 01/2004
2	AntibodiesIBA 06/2004 - 10/2002
2	Ganciclovir (Cytovene)FDA LinkGeneric 03/2004 - 05/2003
1	VaccinesIBA 01/2008
1	ProteomeIBA 10/2006
1	famciclovir (Famvir)FDA LinkGeneric 09/2006
1	abacavir (Ziagen)FDA Link 06/2006
1	Proteins (Proteins, Gene)IBA 06/2006
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2006
1	RNA (Ribonucleic Acid)IBA 03/2006
1	voriconazole (Vfend)FDA Link 10/2005
1	Viral DNAIBA 08/2005
1	emtricitabine (Emtriva)FDA Link 07/2005
1	Chemokine CCL5IBA 09/2004
1	Fluconazole (Zonal)FDA LinkGeneric 02/2004
1	Itraconazole (Sporanox)FDA LinkGeneric 02/2004
1	Biological Markers (Surrogate Marker)IBA 07/2003
1	Interferon-gamma (Interferon, gamma)IBA 06/2003
1	visilizumabIBA 04/2002
1	Acyclovir (Aciclovir)FDA LinkGeneric 04/2002

Therapy/Procedure

7	Transplantation (Transplant Recipients) 06/2007 - 04/2002
6	Transplants (Transplant) 09/2007 - 02/2002
3	Hematopoietic Stem Cell Transplantation 11/2004 - 05/2003
3	Stem Cell Transplantation 11/2003 - 03/2002